ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 60 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 3.99 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $206,000 | -14.2% | 89,815 | 0.0% | 0.00% | -33.3% |
| Q3 2014 | $240,000 | -30.8% | 89,815 | -3.3% | 0.00% | 0.0% |
| Q2 2014 | $347,000 | -87.3% | 92,908 | -60.0% | 0.00% | -88.9% |
| Q1 2014 | $2,735,000 | +122.7% | 232,541 | +58.0% | 0.03% | +125.0% |
| Q4 2013 | $1,228,000 | +44.3% | 147,206 | +60.3% | 0.01% | +33.3% |
| Q3 2013 | $851,000 | +27.0% | 91,821 | +34.4% | 0.01% | +28.6% |
| Q2 2013 | $670,000 | – | 68,320 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 396,104 | $400,000 | 0.42% |
| Ancora Advisors LLC | 50,865 | $51,000 | 0.01% |
| EAGLE GLOBAL ADVISORS LLC | 145,710 | $146,000 | 0.00% |
| Acrospire Investment Management LLC | 5,200 | $5,000 | 0.00% |
| A.R.T. Advisors, LLC | 57,954 | $57,000 | 0.00% |
| Renaissance Technologies | 876,100 | $876,000 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 4,600 | $5,000 | 0.00% |
| Cutler Group LLC / CA | 11,048 | $11,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 133,846 | $134,000 | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 46,100 | $46,000 | 0.00% |